Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

XERSXERS
Showing 8 of 17 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in XERIS BIOPHARMA HOLDINGS INC

Yes. Goldman Sachs holds 1,594,072 shares of XERS (Xeris Biopharma Holdings), worth $12.6M, as of its Q2 2026 13F filing. It reduced the position by 19,578 shares (-1.2%) from Q1 2026. Goldman Sachs has held XERS in every 13F on record since Q2 2022, 17 quarterly filings.

Current Value

$12.6M

Current Shares

1.6M

Total Value Change

+$10.2M

Total Shares Change

+757,630

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.6M
-1.2%
$12.6M0.0%$7.92
0
2026-Q1
Increased
1.6M
+2.9%
$9.4M0.0%$5.94
28
2025-Q4
Decreased
1.6M
-12.6%
$12.3M0.0%$7.31
0
2025-Q3
Decreased
1.8M
-21.0%
$14.6M0.0%$8.08
0
2025-Q2
Decreased
2.3M
-18.6%
$10.6M0.0%$4.70
0
2025-Q1
Increased
2.8M
+75.4%
$15.3M0.0%$5.58
42
2024-Q4
Increased
1.6M
+90.2%
$5.4M0.0%$3.38
43
2024-Q3
Increased
836,442
+165.0%
$2.4M0.0%$2.87
42

Other major holders of XERS: BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used